I was with about 10 other riders at breakfast recently. I happened to hear the word “diabetes” and of course my ears perked up. When I asked Russ and Randy what they were talking about, the subject was food choices and insulin resistance. Seems that one of them had heard …

Woman, 67 years of age, type 2 diabetes for 22 years, class II obesity. Has recently been managing her glucose levels with weight loss, using Tresiba, Trulicity, and metformin. Recent A1C 6.5%, which she’s worked hard for and been extremely proud of. She hasn’t had numbers like she has recently had for years.

In part 5 of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, CA about the cost of PCSK9 inhibitors in the U.S. versus Europe.

In this week's Homerun Slides, understanding insulin resistance issues.

Dyslipidemia: The relationship between cholesterol and cancer risk has been difficult to discern from epidemiologic studies. Individuals with the metabolic syndrome and T2DM frequently have a dyslipidemic profile with elevated triglycerides and decreased high-density lipoprotein cholesterol (HDL-C). In the Metabolic Syndrome Cancer (Me-Can) European cohort elevated triglyceride levels were associated with colon, respiratory, kidney, thyroid cancers, and melanoma in men and respiratory, cervical, and nonmelanoma skin cancers in women.